Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

CD13+Anaplastic Large Cell Lymphoma With Leukemic Presentation and Additional Chromosomal Abnormality (CROSBI ID 160614)

Prilog u časopisu | kratko priopćenje | međunarodna recenzija

Ries, Sunčica ; Rnjak, Lana ; Mitrović, Zdravko ; Gjadrov-Kuveždić, Koraljka ; Nola, Marin ; Sučić, Mirna CD13+Anaplastic Large Cell Lymphoma With Leukemic Presentation and Additional Chromosomal Abnormality // Diagnostic cytopathology, 38 (2010), 2; 141-146. doi: 10.1002/dc.21170

Podaci o odgovornosti

Ries, Sunčica ; Rnjak, Lana ; Mitrović, Zdravko ; Gjadrov-Kuveždić, Koraljka ; Nola, Marin ; Sučić, Mirna

engleski

CD13+Anaplastic Large Cell Lymphoma With Leukemic Presentation and Additional Chromosomal Abnormality

Anaplastic large cell lymphoma (ALCL) is a highly malignant neoplasm characterized by pleomorphic appearance, different immunophenotypes and variable sites of involvement. Expression of myeloid-associated markers in anaplastic large cell lymphomas may mislead the medical team and result in delay of diagnosis due to unusual phenotype. It is important to diagnose this type of tumors and distinguish it from myeloid neoplasms (extramedullary myeloid cell tumors and histiocytic tumors) since therapy and prognosis are significantly different. A 16-year-old female patient presented with fever, lymphadenopathy, and high white blood cell count. Diagnosing a CD13+ ALCL with leukemic presentation with additional cytogenetic abnormality (duplication 5q35) was a significant diagnostic challenge. This combination of features, unusual for lymphoma, should be considered in differential diagnosis of myeloid neoplasms and fatal infections.

lymphoma ; anaplastic large cell

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

38 (2)

2010.

141-146

objavljeno

8755-1039

10.1002/dc.21170

Povezanost rada

Kliničke medicinske znanosti, Farmacija

Poveznice
Indeksiranost